EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metformin normalizes mitochondrial function to delay astrocyte senescence in a mouse model of Parkinson’s disease through Mfn2-cGAS signaling

Min Wang, Tian Tian, Hong Zhou, Si-Yuan Jiang, Ying-Ying Jiao, Zhu Zhu, Jiang Xia, Jian-Hua Ma, Ren-Hong Du

Journal of Neuroinflammation · 02.04.2024 · 21 (1)

DOI: 10.1186/s12974-024-03072-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroinflammation, online erschienen am 02.04.2024. Verfasst von Min Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Affiliated Brain Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu, People's Republic of China. Hauptthemen laut MEDLINE: Parkinson Disease, Metformin. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Senescent astrocytes play crucial roles in age-associated neurodegenerative diseases, including Parkinson’s disease (PD). Metformin, a drug widely used for treating diabetes, exerts longevity effects and neuroprotective activities. However, its effect on astrocyte senescence in PD remains to be defined.

Methods

Long culture-induced replicative senescence model and 1-methyl-4-phenylpyridinium/α-synuclein aggregate-induced premature senescence model, and a mouse model of PD were used to investigate the effect of metformin on astrocyte senescence in vivo and in vitro. Immunofluorescence staining and flow cytometric analyses were performed to evaluate the mitochondrial function. We stereotactically injected AAV carrying GFAP-promoter-cGAS-shRNA to mouse substantia nigra pars compacta regions to specifically reduce astrocytic cGAS expression to clarify the potential molecular mechanism by which metformin inhibited the astrocyte senescence in PD.

Results

We showed that metformin inhibited the astrocyte senescence in vitro and in PD mice. Mechanistically, metformin normalized mitochondrial function to reduce mitochondrial DNA release through mitofusin 2 (Mfn2), leading to inactivation of cGAS-STING, which delayed astrocyte senescence and prevented neurodegeneration. Mfn2 overexpression in astrocytes reversed the inhibitory role of metformin in cGAS-STING activation and astrocyte senescence. More importantly, metformin ameliorated dopamine neuron injury and behavioral deficits in mice by reducing the accumulation of senescent astrocytes via inhibition of astrocytic cGAS activation. Deletion of astrocytic cGAS abolished the suppressive effects of metformin on astrocyte senescence and neurodegeneration.

Conclusions

This work reveals that metformin delays astrocyte senescence via inhibiting astrocytic Mfn2-cGAS activation and suggest that metformin is a promising therapeutic agent for age-associated neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseMetforminMiceAnimalsAstrocytesDopaminergic NeuronsNucleotidyltransferasesMitochondriaGTP Phosphohydrolases

Stichwörter der Autor:innen

Astrocyte senescenceMetforminMitofusin 2Parkinson’s diseasecGAS-STING

Substanzen

MetforminNucleotidyltransferasesMfn2 protein, mouseGTP Phosphohydrolases

Autor:innen und Institutionen

  • Department of Geriatrics, Affiliated Brain Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu, People's Republic of China.
  • Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, 211166, Jiangsu, People's Republic of China.
  • National Demonstration Center for Experimental Basic Medical Education, Nanjing Medical University, Nanjing, 211166, Jiangsu, People's Republic of China.
  • Department of Orthopedics, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, People's Republic of China. vatxia@163.com.
  • Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210000, Jiangsu, People's Republic of China. majianhua196503@126.com.
  • Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, 211166, Jiangsu, People's Republic of China. drh@njmu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, M., Tian, T., Zhou, H., Jiang, S. Y., Jiao, Y. Y., Zhu, Z., Xia, J., Ma, J. H., & Du, R. H. (2024). Metformin normalizes mitochondrial function to delay astrocyte senescence in a mouse model of Parkinson’s disease through Mfn2-cGAS signaling. Journal of Neuroinflammation, 21(1). https://doi.org/10.1186/s12974-024-03072-0

Vancouver

Wang M, Tian T, Zhou H, Jiang SY, Jiao YY, Zhu Z, et al. Metformin normalizes mitochondrial function to delay astrocyte senescence in a mouse model of Parkinson’s disease through Mfn2-cGAS signaling. Journal of Neuroinflammation. 2024;21(1). doi:10.1186/s12974-024-03072-0

BibTeX
@article{Wang2024,
  author = {Wang, Min and Tian, Tian and Zhou, Hong and Jiang, Si-Yuan and Jiao, Ying-Ying and Zhu, Zhu and Xia, Jiang and Ma, Jian-Hua and Du, Ren-Hong},
  title = {Metformin normalizes mitochondrial function to delay astrocyte senescence in a mouse model of Parkinson’s disease through Mfn2-cGAS signaling},
  journal = {Journal of Neuroinflammation},
  year = {2024},
  volume = {21},
  number = {1},
  doi = {10.1186/s12974-024-03072-0}
}
Kostenlos starten →